BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25800725)

  • 1. Identification of human papillomavirus-16 E6 variation in cervical cancer and their impact on T and B cell epitopes.
    Kumar A; Hussain S; Yadav IS; Gissmann L; Natarajan K; Das BC; Bharadwaj M
    J Virol Methods; 2015 Jun; 218():51-8. PubMed ID: 25800725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the impact on T- and B- cell epitopes of human papillomavirus type-16 E6 and E7 variant in Southwest China.
    Chenzhang Y; Wen Q; Ding X; Cao M; Chen Z; Mu X; Wang T
    Immunol Lett; 2017 Jan; 181():26-30. PubMed ID: 27693214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPV16 E6 variants: frequency, association with HPV types and in silico analysis of the identified novel variants.
    Gokhale PS; Sonawani A; Idicula-Thomas S; Kerkar S; Tongaonkar H; Mania-Pramanik J
    J Med Virol; 2014 Jun; 86(6):968-74. PubMed ID: 24610458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus type 16 variant analysis of E6, E7, and L1 genes and long control region in biopsy samples from cervical cancer patients in north India.
    Pande S; Jain N; Prusty BK; Bhambhani S; Gupta S; Sharma R; Batra S; Das BC
    J Clin Microbiol; 2008 Mar; 46(3):1060-6. PubMed ID: 18199779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular variants of HPV-16 associated with cervical cancer in Indian population.
    Pillai MR; Hariharan R; Babu JM; Lakshmi S; Chiplunkar SV; Patkar M; Tongaonkar H; Dinshaw K; Jayshree RS; Reddy BK; Siddiqui M; Roychoudury S; Saha B; Abraham P; Gnanamony M; Peedicayil A; Subhashini J; Ram TS; Dey B; Sharma C; Jain SK; Singh N
    Int J Cancer; 2009 Jul; 125(1):91-103. PubMed ID: 19358280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of immunotherapeutic epitope of E5 protein of human papillomavirus-16: An in silico approach.
    Kumar A; Yadav IS; Hussain S; Das BC; Bharadwaj M
    Biologicals; 2015 Sep; 43(5):344-8. PubMed ID: 26212000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-helper epitopes identified within the E6 transforming protein of cervical cancer-associated human papillomavirus type 16.
    Azoury-Ziadeh R; Herd K; Fernando GJ; Frazer IH; Tindle RW
    Viral Immunol; 1999; 12(4):297-312. PubMed ID: 10630789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic Peptide Prediction From E6 and E7 Oncoproteins of HPV Types 16 and 18 for Therapeutic Vaccine Design Using Immunoinformatics and MD Simulation Analysis.
    Jabbar B; Rafique S; Salo-Ahen OMH; Ali A; Munir M; Idrees M; Mirza MU; Vanmeert M; Shah SZ; Jabbar I; Rana MA
    Front Immunol; 2018; 9():3000. PubMed ID: 30619353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phylogenetic analysis and antigenic epitope prediction for E6 and E7 of Alpha-papillomavirus 9 in Taizhou, China.
    Yuan H; Yan Z; Gan J; Di X; Qiu Y; Xu H
    BMC Genomics; 2024 May; 25(1):507. PubMed ID: 38778248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus type 16 variants in cervical cancer from an admixtured population in Brazil.
    Junes-Gill K; Sichero L; Maciag PC; Mello W; Noronha V; Villa LL
    J Med Virol; 2008 Sep; 80(9):1639-45. PubMed ID: 18649325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of an HLA-A24-restricted cytotoxic T lymphocyte epitope from human papillomavirus type-16 E6: the combined effects of bortezomib and interferon-gamma on the presentation of a cryptic epitope.
    Morishima S; Akatsuka Y; Nawa A; Kondo E; Kiyono T; Torikai H; Nakanishi T; Ito Y; Tsujimura K; Iwata K; Ito K; Kodera Y; Morishima Y; Kuzushima K; Takahashi T
    Int J Cancer; 2007 Feb; 120(3):594-604. PubMed ID: 17096336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPV-16 E6 and E7 protein T cell epitopes prediction analysis based on distributions of HLA-A loci across populations: an in silico approach.
    Yao Y; Huang W; Yang X; Sun W; Liu X; Cun W; Ma Y
    Vaccine; 2013 Apr; 31(18):2289-94. PubMed ID: 23499609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratypic variants of human papillomavirus type 16 and risk of cervical neoplasia in Taiwan.
    Chang YJ; Chen HC; Pan MH; Lee BH; You SL; Lin CY; Chou YC; Hsieh CY; Cheng YJ; Liaw KL; Hsing AW; Schiffman M; Chen CJ;
    J Med Virol; 2013 Sep; 85(9):1567-76. PubMed ID: 23852681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of variants and therapeutic epitopes in HPV-33/HPV-58 E6 and E7 in Southwest China.
    He J; Yang Y; Chen Z; Liu Y; Bao S; Zhao Y; Ding X
    Virol J; 2019 May; 16(1):72. PubMed ID: 31138240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E6 molecular variants of human papillomavirus (HPV) type 16: an updated and unified criterion for clustering and nomenclature.
    Huertas-Salgado A; Martín-Gámez DC; Moreno P; Murillo R; Bravo MM; Villa L; Molano M
    Virology; 2011 Feb; 410(1):201-15. PubMed ID: 21130481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPV prevalence, E6 sequence variation and physical state of HPV16 isolates from patients with cervical cancer in Sichuan, China.
    Qiu AD; Wu EQ; Yu XH; Jiang CL; Jin YH; Wu YG; Chen Y; Chen Y; Shan YM; Zhang GN; Fan Y; Zha X; Kong W
    Gynecol Oncol; 2007 Jan; 104(1):77-85. PubMed ID: 16970982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatics analysis of HPV-68 E6 and E7 oncoproteins for designing a therapeutic epitope vaccine against HPV infection.
    Dong D; Zhu Y; Aili Z; Chen Z; Ding J
    Infect Genet Evol; 2020 Jul; 81():104266. PubMed ID: 32114254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phylogenetic analysis of Human papillomavirus 16 variants isolated from Indian Breast cancer patients showed difference in genetic diversity with that of cervical cancer isolates.
    Islam S; Mazumder Indra D; Basu M; Roychowdhury A; Das P; Dasgupta H; Roy A; Alam N; Mondal RK; Roychoudhury S; Panda CK
    Virus Res; 2018 Jan; 243():1-9. PubMed ID: 28988982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variations in human papillomavirus and cervical cancer outcomes.
    Rader JS; Tsaih SW; Fullin D; Murray MW; Iden M; Zimmermann MT; Flister MJ
    Int J Cancer; 2019 May; 144(9):2206-2214. PubMed ID: 30515767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The genetic variability, phylogeny and functional significance of E6, E7 and LCR in human papillomavirus type 52 isolates in Sichuan, China.
    Song Z; Cui Y; Li Q; Deng J; Ding X; He J; Liu Y; Ju Z; Fang L
    Virol J; 2021 May; 18(1):94. PubMed ID: 33941222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.